Home > Boards > US Listed > Biotechs >

Kindred Biosciences Inc (KIN)

KIN RSS Feed
Add KIN Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 2/20/2021 7:21:12 PM - Followers: 7 - Board type: Free - Posts Today: 0



https://www.kindredbio.com/

https://www.kindredbio.com/management-and-team/
https://www.kindredbio.com/
https://www.kindredbio.com/pipeline/

 

Kindred Biosciences Announces Plan to Strengthen its Strategic Position

June 8, 2020

SAN FRANCISCO , June 8, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

May 20, 2020

SAN FRANCISCO , May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...

Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference

May 13, 2020

SAN FRANCISCO , May 13, 2020 /PRNewswire/ -- Kindred Biosciences , Inc. (NASDAQ: ... 

Kindred Biosciences Announces First Quarter 2020 Financial Results

May 7, 2020

SAN FRANCISCO , May 7, 2020 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce First Quarter 2020 Financial Results

April 23, 2020

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P... 

Kindred Biosciences Announces Completion of Mirataz® (mirtazapine transdermal ointment) Transaction

April 15, 2020

$KIN 07-29-2020 btm.Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
May 20, 2020
San Francisco, California (May 20, 2020) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics,

today announced it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT) for the manufacture of Vaxart’s oral vaccine candidate for COVID-19.

“We are proud to be contributing toward the effort to develop a COVID-19 vaccine.

We look forward to working with Vaxart to bring this innovative technology to patients as quickly as possible,” said KindredBio’s Chief Executive Officer,

Richard Chin, M.D.
“This marks an important step in the development of our contract manufacturing business, which has the potential to help fund our promising pipeline.”

Under the terms of the agreement, KindredBio will provide manufacturing services from its state-of-the-art biological development and cGMP manufacturing facility in Burlingame, CA.

There, KindredBio will produce the candidate vaccine bulk drug substance under Good Manufacturing Practices,
and provide it to Vaxart to be
formulated into a vaccine tablet to be taken by mouth
instead of by needle injection.

KindredBio will manufacture the vaccine for clinical trials beginning in the second half of 2020.

“We are pleased to be partnering with Kindred Biosciences in the development of our oral COVID-19 vaccine candidate,” said Vaxart’s Chief Executive Officer,

Wouter Latour, M.D.
“We believe our novel approach utilizing a room temperature-stable tablet offers important logistical advantages in widespread oral vaccination,
and that KindredBio with its state-of-the-art manufacturing plants is
an ideal partner to realize our vision.”

KindredBio’s core expertise includes protein engineering,
cell line development,
master cell banking, process development, assay development, stability testing, and
cGMP clinical and
commercial manufacturing from 50 litres to 2,000 litres.




https://finviz.com/quote.ashx?t=kin&ty=c&ta=1&p=d



Manufacturing 'Kindred Biosciences Inc (KIN)'
KindredBio’s manufacturing facilities provide a seamless transfer from 
the research and development stage, 
to the commercial manufacturing stage. 

https://www.kindredbio.com/manufacturing-process/

Our team maintains control over all steps and processes and provides 
a unique setting for the development and manufacturing of high-quality, species-specific veterinary biologics.

High standards create dependability when your pet needs it most
The quality of our biologics and pharmaceuticals is just as important
 as their development.

KindredBio will manufacture products under the appropriate 
regulatory frameworks such as Title 9 and Title 21 of the Code of Federal Regulations for products being licensed through the 
USDA and FDA respectively. 

KindredBio manufacturing sites in Burlingame, CA and Elwood, 
KS follow Current Good Manufacturing Practices (cGMP).

KindredBio acquired, retrofitted, and commissioned an additional manufacturing facility in Elwood, Kansas. 

We are uniquely positioned to meet the manufacturing needs of 
our promising pipeline with combined facilities reaching 
180,000 square feet of full-spectrum production, 
from infancy to commercialization, 
including labeling and packaging end-to-end processes. 

KindredBio Clinical and Commercial Manufacturing can support the production of a broad range of biologics and pharmaceuticals. 

This is done through the use of single-use bioreactor 
(SUB) up to 2,000L in size and the use of automated vial filling, labeling, and cartoning equipment providing flexibility throughout 
the process.

[-chart]www.kindredbio.com/wp-content/uploads/2020/02/burlingame-outside-1.jpg[/chart]




In addition to the Kansas facility, KindredBio commissioned its own dedicated cGMP biologics manufacturing facility in close proximity 
to our development labs in Burlingame, California. 

The facility utilizes state-of-the-art single-use technology and 
has the capacity to meet the requirements for the small scale 
clinical and commercial KindredBio biologics supply.

KindredBio is one of the few biopharmaceutical manufacturers that 
can capitalize on its production capacity and maintain a steady 
revenue stream while ensuring all fulfillment needs are met.

KindredBio provides full service contract development and manufacturing activities, 
which are managed by a wholly owned subsidiary, Centaur Biopharmaceutical Services.






$KIN  https://www.otcmarkets.com/stock/KIN/disclosure

https://www.otcmarkets.com/stock/KIN/news

https://www.otcmarkets.com/stock/KIN/security
KIN SECURITY DETAILS Market Cap Market Cap 197,244,065 02/01/2021

Authorized Shares.........Not Available
Outstanding Shares......39,448,813
11/05/2020

https://www.otcmarkets.com/stock/KIN/profile

https://www.otcmarkets.com/stock/KIN/quote

https://www.otcmarkets.com/stock/KIN/overview







 

PER MGMT DAVE - 

IH Geek [Dave] DISCLAIMER
 

01-31-2021
DISCLAIMER:  ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
 
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION 
AUTHORS MAY HAVE BUYS OR SELLS  WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.

ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Any






 






 
KIN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KIN News: Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference 03/02/2021 08:31:00 AM
KIN News: Kindred submits efficacy data to support KIND-030 prophylactic indication approval 02/25/2021 08:22:43 AM
KIN News: Current Report Filing (8-k) 02/25/2021 08:13:53 AM
KIN News: Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication 02/25/2021 08:01:00 AM
KIN News: Statement of Changes in Beneficial Ownership (4) 02/23/2021 04:55:49 PM
PostSubject
#116  Sticky Note $KIN 08-20-2020 Nasdaq:[pill form] VXRT for the manufacture mick 02/02/21 03:56:42 PM
#130   Kindred Biosciences (KIN) mick 02/20/21 07:21:12 PM
#129   A..H. PLAY $KIN Bid Ask Day's Range 5.0 5.06 4.85 - 5.15 mick 02/02/21 06:54:33 PM
#128   F.D.A. great read KindredBio Partners with Vaxart for mick 02/02/21 05:40:44 PM
#127   F.D.A. great read KindredBio Partners with Vaxart for mick 02/02/21 05:40:43 PM
#126   A.H. PLAY $KIN Bid: 5.00 Ask: 5.03 Last: mick 02/02/21 05:24:43 PM
#125   A.H. PLAY $KIN Bid: 5.00 Ask: 5.03 Last: mick 02/02/21 05:24:43 PM
#124   'Kindred Biosciences Inc (KIN)' PRESS RELEASE mick 02/02/21 05:21:30 PM
#123   excerpt $KIN Kindred Biosciences Announces Plan to Strengthen mick 02/02/21 05:12:04 PM
#122   $KIN Kindred Biosciences Initiates Pivotal Efficacy Study of mick 02/02/21 05:10:16 PM
#121   $4.95 Stock is Down -0.05 (-1.00%) 'Kindred mick 02/02/21 04:48:54 PM
#120   Manufacturing 'Kindred Biosciences Inc (KIN)' mick 02/02/21 04:44:08 PM
#119   NEEDS UPDATED MY FRIEND 'Kindred Biosciences Inc (KIN)' mick 02/02/21 04:34:48 PM
#118   Shs Outstand 39.31M 'Kindred Biosciences Inc (KIN)' mick 02/02/21 04:28:14 PM
#117   KIN SECURITY DETAILS Market Cap Market Cap 197,244,065 02/01/2021 mick 02/02/21 04:12:15 PM
#116   $KIN 08-20-2020 Nasdaq:[pill form] VXRT for the manufacture mick 02/02/21 03:56:42 PM
#115   $KIN & $VXRT THEN 1. Oral formulations vs mick 02/02/21 03:49:50 PM
#114   who is in partners wit 'Kindred Biosciences Inc mick 02/02/21 03:20:02 PM
#113   https://otcbb.swingtradebot.com/equities/KIN N.Y. , NASDAQ mick 01/31/21 04:04:36 PM
#112   https://pennystocks.news/otc/?symbol=KIN mick 01/03/21 11:58:28 AM
#111   Kindred Biosciences (KIN) mick 12/07/20 12:37:14 PM
#110   Kindred Biosciences (KIN) mick 11/24/20 08:10:48 PM
#109   Kindred Biosciences (KIN) mick 10/25/20 04:26:15 PM
#108   Kindred Biosciences (KIN) mick 09/24/20 09:15:55 PM
#107   Kindred Biosciences (KIN) mick 09/17/20 12:39:41 AM
#106   THANK YOU, $KIN mick 09/17/20 12:39:22 AM
#105   KIN chart update :-) manysevens 09/16/20 10:12:27 PM
#104   Just In: $KIN Kindred Biosciences Announces Positive Results whytestocks 09/16/20 04:15:24 PM
#103   Kindred Biosciences (KIN) mick 09/05/20 03:07:02 PM
#102   $KIN BARRY VERY BULLISH CHECK YOUR CHART !!!!! mick 08/20/20 09:16:32 PM
#101   Took the day off today but I'm right manysevens 08/20/20 08:24:18 PM
#100   $KIN huge earnings report[heavy]Kindred Biosciences Q2 EPS $0.60 mick 08/20/20 07:54:19 PM
#99   $KIN huge earnings report[heavy]Kindred Biosciences Q2 EPS $0.60 mick 08/20/20 07:54:19 PM
#98   $KIN making breakout move my friend , why mick 08/20/20 07:50:52 PM
#97   $KIN 08-20-2020 Nasdaq:[pill form] VXRT for the manufacture mick 08/20/20 10:33:26 AM
#96   $KIN Pay Attention to dis Partnering wit $VXRT mick 08/20/20 10:29:23 AM
#95   $KIN https://www.otcmarkets.com/stock/KIN/overview mick 08/20/20 10:27:10 AM
#94   https://www.otcmarkets.com/stock/KIN/quote mick 08/20/20 10:26:56 AM
#93   https://www.otcmarkets.com/stock/KIN/profile mick 08/20/20 10:26:39 AM
#92   https://www.otcmarkets.com/stock/KIN/profile mick 08/20/20 10:26:39 AM
#91   https://www.otcmarkets.com/stock/KIN/security mick 08/20/20 10:26:19 AM
#90   https://www.otcmarkets.com/stock/KIN/news mick 08/20/20 10:26:03 AM
#89   https://www.otcmarkets.com/stock/KIN/news mick 08/20/20 10:26:03 AM
#88   $KIN https://www.otcmarkets.com/stock/KIN/disclosure mick 08/20/20 10:25:43 AM
#87   $KIN THIS DREW ME HERE PARTNERSHIP WIT VXRT mick 08/20/20 10:25:01 AM
#86   $KIN THIS DREW ME HERE PARTNERSHIP WIT VXRT mick 08/20/20 10:25:00 AM
#85   $KIN DIS CHART [$KIN *V* BREAKOUT POSSIBLE REVERSE mick 08/20/20 10:23:13 AM
#84   $KIN I LIKE YOUR BREAKOUT ANYTIME[SAUCER FORMATION] mick 08/20/20 10:17:47 AM
#83   $KIN Relieve Pyrexia[only drug FDA-approved for control of mick 08/18/20 03:35:32 PM
#82   $KIN 7-29-2020 btm call;[da pill]Nasdaq:VXRT for the manufacture mick 08/18/20 03:28:36 PM
#81   $KIN 7-29-2020 btm call;Nasdaq:VXRT for the manufacture of mick 08/18/20 03:28:36 PM
PostSubject
Consent Preferences